3/10
08:35 am
rnac
Cartesian Therapeutics (RNAC) had its "outperform" rating reaffirmed by Wedbush. They now have a $38.00 price target on the stock.
Medium
Report
Cartesian Therapeutics (RNAC) had its "outperform" rating reaffirmed by Wedbush. They now have a $38.00 price target on the stock.
3/10
08:35 am
rnac
Cartesian Therapeutics (RNAC) had its "outperform" rating reaffirmed by Wedbush. They now have a $38.00 price target on the stock.
Medium
Report
Cartesian Therapeutics (RNAC) had its "outperform" rating reaffirmed by Wedbush. They now have a $38.00 price target on the stock.
3/10
08:22 am
rnac
Rating for RNAC
Medium
Report
Rating for RNAC
3/10
08:22 am
rnac
Rating for RNAC
Medium
Report
Rating for RNAC
3/9
06:05 pm
rnac
Cartesian Therapeutics (RNAC) had its "buy" rating reaffirmed by BTIG Research.
Medium
Report
Cartesian Therapeutics (RNAC) had its "buy" rating reaffirmed by BTIG Research.
3/9
12:52 pm
rnac
Rating for RNAC
Medium
Report
Rating for RNAC
3/9
12:42 pm
rnac
Cartesian Therapeutics (RNAC) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $42.00 price target on the stock.
Medium
Report
Cartesian Therapeutics (RNAC) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $42.00 price target on the stock.
3/9
12:23 pm
rnac
Rating for RNAC
Medium
Report
Rating for RNAC
3/9
12:23 pm
rnac
Rating for RNAC
Medium
Report
Rating for RNAC
3/9
11:00 am
rnac
Cartesian Therapeutics (RNAC) was upgraded by Cantor Fitzgerald from "neutral" to "overweight". They now have a $16.00 price target on the stock.
High
Report
Cartesian Therapeutics (RNAC) was upgraded by Cantor Fitzgerald from "neutral" to "overweight". They now have a $16.00 price target on the stock.
3/9
10:57 am
rnac
Cartesian Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
High
Report
Cartesian Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
3/9
10:57 am
rnac
Correction: Cartesian Therapeutics upgraded at Cantor Fitzgerald
High
Report
Correction: Cartesian Therapeutics upgraded at Cantor Fitzgerald
3/9
10:56 am
rnac
Cartesian Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
High
Report
Cartesian Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
3/9
10:55 am
rnac
Cartesian Therapeutics upgraded to Buy from Hold at Canaccord
High
Report
Cartesian Therapeutics upgraded to Buy from Hold at Canaccord
1/9
10:54 am
rnac
Rating for RNAC
Medium
Report
Rating for RNAC
1/9
10:54 am
rnac
Rating for RNAC
Medium
Report
Rating for RNAC